On January 3, 2019 the Government of India through the Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) amended the Drugs (Price Control) Order, 2013 (DPCO) to exempt new patented drugs from price control for five years from the date of commencement of its commercial marketing by the manufacturer. The DPCO fixes the prices of scheduled formulations and monitors maximum..
Pankaj Musyuni discuss about the topic of No Price Control On New Drugs Patented in India in his Mondaq article, which can be viewed at http://www.mondaq.com/article.